Inhibition of Dog and Human Gastric Lipases by Enantiomeric Phosphonate Inhibitors: A Structure-Activity Study
详细信息    查看全文
文摘
The crystal structures of gastric lipases in the apo form [Roussel, A., et al. (1999) J. Biol.Chem. 274, 16995-17002] or in complex with the (RP)-undecyl butyl phosphonate [C11Y4(+)] [Roussel,A., et al. (2002) J. Biol. Chem. 277, 2266-2274] have improved our understanding of the structure-activity relationships of acid lipases. In this report, we have performed a kinetic study with dog andhuman gastric lipases (DGL and HGL, respectively) using several phosphonate inhibitors by varying theabsolute configuration of the phosphorus atom and the chain length of the alkyl/alkoxy substitutents.Using the two previously determined structures and that of a new crystal structure obtained with the other(SP)-phosphonate enantiomer [C11Y4(-)], we constructed models of phosphonate inhibitors fitting intothe active site crevices of DGL and HGL. All inhibitors with a chain length of fewer than 12 carbonatoms were found to be completely buried in the catalytic crevice, whereas longer alkyl/alkoxy chainswere found to point out of the cavity. The main stereospecific determinant explaining the stronger inhibitionof the SP enantiomers is the presence of a hydrogen bond involving the catalytic histidine as found in theDGL-C11Y4(-) complex. On the basis of these results, we have built a model of the first tetrahedralintermediate corresponding to the tristearoyl-lipase complex. The triglyceride molecule completely fillsthe active site crevice of DGL, in contrast with what is observed with other lipases such as pancreaticlipases which have a shallower and narrower active site. For substrate hydrolysis, the supply of watermolecules to the active site might be achieved through a lateral channel identified in the protein core.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700